iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionAlbion Financial Group /ut
Latest Disclosed Ownership120,147 shares
Latest Disclosed Value $ 20,286,892
Albion Financial Group /ut reports 0.34% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 27, 2026 - Albion Financial Group /ut filed a 13F-HR form disclosing ownership of 120,147 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $20,286,892 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 119,737 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.34% during the quarter. The current value of the position is $15,745,264 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 120,147 410 0.34 20,287 0.39 1.3090
2026-01-21 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 119,737 -3,615 -2.93 20,208 13.48 1.2577
2025-10-20 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 123,352 -641 -0.52 17,808 13.53 1.0755
2025-07-17 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 123,993 172 0.14 15,686 -0.95 1.0248
2025-04-25 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 123,821 -4,877 -3.79 15,837 -6.93 1.1203
2025-01-17 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 128,698 -1,282 -0.99 17,015 -10.09 1.1645
2024-10-09 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 129,980 356 0.27 18,925 6.37 1.3131
2024-07-10 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 129,624 14 0.01 17,792 0.04 1.3404
2024-04-19 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 129,610 233 0.18 17,785 1.19 1.3729
2024-01-26 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 129,377 1,575 1.23 17,576 12.46 1.4484
2023-11-01 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 127,802 7,375 6.12 15,629 2.22 1.4423
2023-07-25 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 120,427 -9,287 -7.16 15,289 -8.74 1.3382
2023-04-18 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 129,714 784 0.61 16,754 -1.03 1.5327
2023-02-03 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 128,930 38 0.03 16,927 12.29 1.6345
2022-10-27 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 128,892 835 0.65 15,075 0.08 1.5559
2022-07-29 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 128,057 4,424 3.58 15,063 -6.49 1.4923
2022-05-09 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 123,633 2,403 1.98 16,109 -12.93 1.3712
2022-02-15 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 121,230 2,831 2.39 18,502 -3.35 1.4656
2021-10-19 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 118,399 8,748 7.98 19,143 6.68 1.6768
2021-08-12 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 109,651 4,996 4.77 17,944 13.18 1.5556
2021-02-19 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 104,655 3,307 3.26 15,854 15.52 1.5537
2020-11-13 2020-09-30 13F iShares Nasdaq Biotech COM 464287556 101,348 561 0.56 13,724 -0.38 1.4863
2020-08-17 2020-06-30 13F iShares Nasdaq Biotech COM 464287556 100,787 1,347 1.35 13,777 28.59 1.6258
2020-05-08 2020-03-31 13F iShares Nasdaq Biotech COM 464287556 99,440 1,698 1.74 10,714 -9.04 1.5646
2020-01-31 2019-12-31 13F iShares Nasdaq Biotech COM 464287556 97,742 673 0.69 11,779 21.96 1.3977
2019-11-08 2019-09-30 13F iShares Nasdaq Biotech COM 464287556 97,069 -5,773 -5.61 9,658 -13.92 1.2385
2019-08-08 2019-06-30 13F iShares Nasdaq Biotech COM 464287556 102,842 -1,659 -1.59 11,220 -3.96 1.4486
2019-05-14 2019-03-31 13F iShares Nasdaq Biotech COM 464287556 104,501 2,926 2.88 11,683 19.28 1.5844
2019-01-28 2018-12-31 13F iShares Nasdaq Biotech COM 464287556 101,575 1,273 1.27 9,795 -19.92 1.5258
2018-11-20 2018-09-30 13F iShares Nasdaq Biotech COM 464287556 100,302 1,919 1.95 12,231 13.21 1.6548
2018-08-14 2018-06-30 13F iShares Nasdaq Biotech COM 464287556 98,383 1,104 1.13 10,804 4.04 1.5571
2018-04-17 2018-03-31 13F/A-1 iShares Nasdaq Biotech COM 464287556 97,279 444 0.46 10,384 0.44 1.5966
2018-04-17 2018-03-31 13F iShares Nasdaq Biotech COM 464287556 97,279 10,384
2018-02-21 2017-12-31 13F iShares Nasdaq Biotech COM 464287556 96,835 64,472 199.22 10,339 -4.23 1.5744
2017-11-09 2017-09-30 13F iShares Nasdaq Biotech COM 464287556 32,363 2,544 8.53 10,796 16.76 1.6487
2017-08-15 2017-06-30 13F iShares Nasdaq Biotech COM 464287556 29,819 50 0.17 9,246 5.91 1.5360
2017-05-15 2017-03-31 13F iShares Nasdaq Biotech COM 464287556 29,769 27,368 1,139.86 8,730 1,270.49 1.3103
2017-02-14 2016-12-31 13F/A-1 iShares Nasdaq Biotech COM 464287556 2,401 -20 -0.83 637 -9.13 0.1054
2016-11-03 2016-09-30 13F iShares Nasdaq Biotech COM 464287556 2,421 2,421 0.00 701 0.1200
2016-04-21 2016-03-31 13F iShares Nasdaq Biotech COM 464287556 0 -29,336 -100.00 0 -100.00
2016-02-22 2015-12-31 13F iShares Nasdaq Biotech COM 464287556 29,336 45 0.15 9,925 11.71 1.7067
2015-11-04 2015-09-30 13F iShares Nasdaq Biotech COM 464287556 29,291 163 0.56 8,885 -17.33 1.6083
2015-07-27 2015-06-30 13F iShares Nasdaq Biotech COM 464287556 29,128 192 0.66 10,747 8.14 1.7858
2015-05-14 2015-03-31 13F iShares Nasdaq Biotech COM 464287556 28,936 727 2.58 9,938 16.14 1.6874
2015-02-26 2014-12-31 13F iShares Nasdaq Biotech COM 464287556 28,209 -18,226 -39.25 8,557 -32.65 1.4776
2014-11-13 2014-09-30 13F iShares Nasdaq Biotech COM 464287556 46,435 338 0.73 12,706 7.24 2.2498
2014-08-18 2014-06-30 13F iShares Nasdaq Biotech COM 464287556 46,097 2,203 5.02 11,848 14.18 2.0515
2014-05-13 2014-03-31 13F iShares Nasdaq Biotechnology I COM 464287556 43,894 1,765 4.19 10,377 8.48 1.9139
2014-02-13 2013-12-31 13F iShares Nasdaq Biotechnology I COM 464287556 42,129 135 0.32 9,566 8.68 1.7937
2013-11-19 2013-09-30 13F iShares Nasdaq Biotechnology I COM 464287556 41,994 3,678 9.60 8,802 32.12 1.8778
2013-08-16 2013-06-30 13F iShares Nasdaq Biotechnology I COM 464287556 38,316 38,316 6,662 1.4802
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.